Assyro AI

Orange Book product · Generic (ANDA)

LAMIVUDINE

LAMIVUDINE

Generic (ANDA)ANDA 077695TE AARX AUROBINDO PHARMA
View LAMIVUDINE familyOpen on FDA Orange Book

At a glance

Nov 21, 2016

Approved

Generic (ANDA)

Application

AA

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Nov 21, 2016

    9 yr 9 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

LAMIVUDINE

Strength

10MG/ML

Dosage form

SOLUTION

Route

ORAL

TE code

AA

Application

ANDA 077695

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of LAMIVUDINE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo